A treatment that could more than double the life expectancy of prostate cancer sufferers has been hailed as a once-in-a-career discovery. Researchers believe giving patients two drug treatments at once cuts disease progression and offers some patients the chance of a cure. It could help 20,000 men who are diagnosed with the illness each year. Those with
the most advanced form of the disease, about 5,000, could see their life expectancy jump from 3.5 years to seven years on average. Of the 15,000 diagnosed when the disease had not spread, most could expect to live as long as they would if they were cancer-free. The clinical trial, run by Cancer Research UK and believed to be the biggest cancer trial in the world, included about 1,900 men diagnosed with advanced prostate cancer which had not spread. READ MORE
